These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14769712

  • 1. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.
    Kochiadakis GE, Igoumenidis NE, Hamilos MI, Tzerakis PG, Klapsinos NC, Zacharis EA, Vardas PE.
    Chest; 2004 Feb; 125(2):377-83. PubMed ID: 14769712
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
    Martínez-Marcos FJ, García-Garmendia JL, Ortega-Carpio A, Fernández-Gómez JM, Santos JM, Camacho C.
    Am J Cardiol; 2000 Nov 01; 86(9):950-3. PubMed ID: 11053705
    [Abstract] [Full Text] [Related]

  • 3. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
    Kochiadakis GE, Marketou ME, Igoumenidis NE, Chrysostomakis SI, Mavrakis HE, Kaleboubas MD, Vardas PE.
    Pacing Clin Electrophysiol; 2000 Nov 01; 23(11 Pt 2):1883-7. PubMed ID: 11139949
    [Abstract] [Full Text] [Related]

  • 4. Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group.
    Blanc JJ, Voinov C, Maarek M.
    Am J Cardiol; 1999 Nov 01; 84(9):1029-32. PubMed ID: 10569658
    [Abstract] [Full Text] [Related]

  • 5. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G, PITAGORA Study Investigators.
    Am Heart J; 2008 Jan 01; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [Abstract] [Full Text] [Related]

  • 6. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
    Zapolski T, Wysokiński A.
    Kardiol Pol; 2005 Sep 01; 63(3):254-62; discussion 263-4. PubMed ID: 16180181
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
    Am J Cardiol; 2001 Sep 15; 88(6):640-5. PubMed ID: 11564387
    [Abstract] [Full Text] [Related]

  • 8. Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation.
    Di Biasi P, Scrofani R, Paje A, Cappiello E, Mangini A, Santoli C.
    Eur J Cardiothorac Surg; 1995 Sep 15; 9(10):587-91. PubMed ID: 8562105
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE, Igoumenidis NE, Hamilos ME, Marketou ME, Chlouverakis GI, Vardas PE.
    Am J Cardiol; 2007 Jun 15; 99(12):1721-5. PubMed ID: 17560882
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I, Petrela E, Kondili A.
    Anadolu Kardiyol Derg; 2011 Nov 15; 11(7):600-6. PubMed ID: 21911317
    [Abstract] [Full Text] [Related]

  • 11. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study.
    Vardas PE, Kochiadakis GE, Igoumenidis NE, Tsatsakis AM, Simantirakis EN, Chlouverakis GI.
    Chest; 2000 Jun 15; 117(6):1538-45. PubMed ID: 10858380
    [Abstract] [Full Text] [Related]

  • 12. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
    N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
    Dogan A, Ergene O, Nazli C, Kinay O, Altinbas A, Ucarci Y, Ergene U, Ozaydin M, Gedikli O.
    Acta Cardiol; 2004 Jun 30; 59(3):255-61. PubMed ID: 15255456
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
    Cardiol J; 2009 Jun 30; 16(6):521-7. PubMed ID: 19950088
    [Abstract] [Full Text] [Related]

  • 15. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study.
    Kochiadakis GE, Igoumenidis NE, Simantirakis EN, Marketou ME, Parthenakis FI, Mezilis NE, Vardas PE.
    Pacing Clin Electrophysiol; 1998 Nov 30; 21(11 Pt 2):2475-9. PubMed ID: 9825370
    [Abstract] [Full Text] [Related]

  • 16. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A, Karnad D, Goyal V, Naik A, Gupta A, Lokhandwala Y, Kulkarni H, Singh B.
    Indian Heart J; 2004 Nov 30; 56(2):110-6. PubMed ID: 15377131
    [Abstract] [Full Text] [Related]

  • 17. [The efficacy of intravenous propafenone and amiodarone in the conversion of recent-onset atrial fibrillation. A 1-year follow-up with oral treatment].
    Bellandi F, Cantini F, Pedone T, Dabizzi RP, Palchetti R.
    G Ital Cardiol; 1993 Mar 30; 23(3):261-71. PubMed ID: 8325461
    [Abstract] [Full Text] [Related]

  • 18. Short-term amiodarone therapy after reversion of persistent atrial fibrillation reduces recurrences at 18 months.
    Galperin J, Elizari MV, Bonato R, Ledesma R, Vazquez Blanco M, Lago M, Spada P, Sanchez J, Piasentin J, Chiale PA.
    Cardiol J; 2014 Mar 30; 21(4):397-404. PubMed ID: 24293165
    [Abstract] [Full Text] [Related]

  • 19. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
    Ad N, Holmes SD, Shuman DJ, Pritchard G, Miller CE.
    J Thorac Cardiovasc Surg; 2016 Mar 30; 151(3):798-803. PubMed ID: 26253874
    [Abstract] [Full Text] [Related]

  • 20. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
    Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Kowey PR.
    J Cardiovasc Electrophysiol; 2012 May 30; 23(5):462-72. PubMed ID: 22171925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.